Cargando…

Systematic review of the pharmacological treatment of alcohol use disorders in individuals infected with hepatitis C

Treating alcohol use disorders (AUD) is critical in individuals suffering from hepatitis C infection (HCV). Aside from psychosocial interventions, pharmacological treatment is effective for decreasing alcohol consumption and promoting abstinence. However, unique factors belonging to HCV-infected ind...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thibault, Alexis, Brissette, Suzanne, Jutras-Aswad, Didier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4636805/ https://www.ncbi.nlm.nih.gov/pubmed/25928362 http://dx.doi.org/10.1186/s13722-015-0029-2

Ejemplares similares

Cannabidiol as a treatment for craving and relapse in individuals with cocaine use disorder: a randomized placebo‐controlled trial
por: Mongeau‐Pérusse, Violaine, et al.
Publicado: (2021)

Portraying Persons Who Inject Drugs Recently Infected with Hepatitis C Accessing Antiviral Treatment: A Cluster Analysis
por: Bamvita, Jean-Marie, et al.
Publicado: (2014)

A case of hypomania during nicotine cessation treatment with bupropion
por: Giasson-Gariépy, Karine, et al.
Publicado: (2013)

Cannabidiol as an Intervention for Addictive Behaviors: A Systematic Review of the Evidence
por: Prud’homme, Mélissa, et al.
Publicado: (2015)

Effects of Buprenorphine/Naloxone and Methadone on Depressive Symptoms in People with Prescription Opioid Use Disorder: A Pragmatic Randomised Controlled Trial
por: Bastien, Gabriel, et al.
Publicado: (2022)

Implementation of a contingency approach for people with co-occurring substance use and psychiatric disorders: Acceptability and feasibility pilot study
por: Desrosiers, Julie J., et al.
Publicado: (2019)

Modulation of the Endocannabinoid System: Vulnerability Factor and New Treatment Target for Stimulant Addiction
por: Olière, Stéphanie, et al.
Publicado: (2013)

Changes in Alcohol Habits Among Workers During the Confinement of COVID-19: Results of a Canadian Cross-Sectional Survey
por: Mongeau-Pérusse, Violaine, et al.
Publicado: (2021)

Outcomes associated with nonmedical cannabis legalization policy in Canada: taking stock at the 5-year mark
por: Fischer, Benedikt, et al.
Publicado: (2023)

Experiences and perceptions of nurses participating in an interprofessional, videoconference-based educational programme on concurrent mental health and substance use disorders: a qualitative study
por: Chicoine, Gabrielle, et al.
Publicado: (2022)

Risk-thresholds for the association between frequency of cannabis use and the development of psychosis: a systematic review and meta-analysis
por: Robinson, Tessa, et al.
Publicado: (2023)

Intravenous ketamine for benzodiazepine deprescription and withdrawal management in treatment-resistant depression: a preliminary report
por: Garel, Nicolas, et al.
Publicado: (2023)

Sensitivity to change of generic preference-based instruments (EQ-5D-3L, EQ-5D-5L, and HUI3) in the context of treatment for people with prescription-type opioid use disorder in Canada
por: Whitehurst, David G. T., et al.
Publicado: (2023)

Co-exposure of cannabinoids with amphetamines and biological, behavioural and health outcomes: a scoping review of animal and human studies
por: Daldegan-Bueno, Dimitri, et al.
Publicado: (2021)

Impact of a videoconferencing educational programme for the management of concurrent disorders on nurses’ competency development and clinical practice: protocol for a convergent mixed methods study
por: Chicoine, Gabrielle, et al.
Publicado: (2021)

Medication treatment of alcohol use disorders in veterans with Hepatitis C
por: Hauser, Peter
Publicado: (2010)

Impact of an Accelerated Pretreatment Evaluation on Linkage-to-Care for Hepatitis C-infected Persons Who Inject Drugs
por: Martel-Laferrière, Valérie, et al.
Publicado: (2022)

Novel Agents for the Pharmacological Treatment of Alcohol Use Disorder
por: Burnette, Elizabeth M., et al.
Publicado: (2022)

Technology-Based Psychological Interventions for Young Adults With Early Psychosis and Cannabis Use Disorder: Qualitative Study of Patient and Clinician Perspectives
por: Tatar, Ovidiu, et al.
Publicado: (2021)

Alcohol use disorder: pathophysiology, effects, and pharmacologic options for treatment
por: Wackernah, Robin C, et al.
Publicado: (2014)

Neurotensin and Alcohol Use Disorders: Towards a Pharmacological Treatment
por: Rodríguez, Francisco D., et al.
Publicado: (2023)

Effectiveness and experiences of the Extension for Community Healthcare Outcomes (ECHO) Model in developing competencies among healthcare professionals: a mixed methods systematic review protocol
por: Chicoine, Gabrielle, et al.
Publicado: (2021)

Prevalence of Hepatitis B and C virus infection among alcoholic individuals: importance of screening and vaccination
por: Cortes, Vanessa Faria, et al.
Publicado: (2017)

Alcohol use disorders and the risk of progression of liver disease in people with hepatitis C virus infection – a systematic review
por: Llamosas-Falcón, Laura, et al.
Publicado: (2020)

Discrete time measures versus trajectories of drinking frequency across adolescence as predictors of binge drinking in young adulthood: a longitudinal investigation
por: Sylvestre, Marie-Pierre, et al.
Publicado: (2020)

Possible new ways in the pharmacological treatment of bipolar disorder and comorbid alcoholism
por: Azorin, Jean-Michel, et al.
Publicado: (2010)

Social Robot Interventions in Mental Health Care and Their Outcomes, Barriers, and Facilitators: Scoping Review
por: Guemghar, Imane, et al.
Publicado: (2022)

Pharmacological Treatment of Alcohol Cravings
por: Marin, Matheus Cheibub David, et al.
Publicado: (2023)

Cannabis-Dependence Risk Relates to Synergism between Neuroticism and Proenkephalin SNPs Associated with Amygdala Gene Expression: Case-Control Study
por: Jutras-Aswad, Didier, et al.
Publicado: (2012)

Alcohol and Hepatitis C
por: Lieber, Charles S.
Publicado: (2001)

Hepatitis C and Alcohol
por: Schiff, Eugene R., et al.
Publicado: (2003)

Alcohol use disorder treatment and outcomes among hospitalized adults with alcoholic hepatitis
por: Winters, Adam C., et al.
Publicado: (2021)

Pharmacological and non-pharmacological treatments for major depressive disorder: review of systematic reviews
por: Gartlehner, Gerald, et al.
Publicado: (2017)

The role of daily goal setting among individuals with alcohol use disorder
por: Treloar Padovano, Hayley, et al.
Publicado: (2022)

Alcohol use disorder and its impact on chronic hepatitis C virus and human immunodeficiency virus infections
por: Fuster, Daniel, et al.
Publicado: (2016)

Infections in Alcoholic Hepatitis
por: Kaur, Bhupinder, et al.
Publicado: (2022)

Use of non-medical cannabis in epilepsy: A scoping review
por: Li, Jimmy, et al.
Publicado: (2023)

Current and potential pharmacological treatment options for insomnia in patients with alcohol use disorder in recovery
por: Roehrs, Timothy A., et al.
Publicado: (2020)

Association Between Alcohol Use Disorder and Receipt of Direct-Acting Antiviral Hepatitis C Virus Treatment
por: Haque, Lamia Y., et al.
Publicado: (2022)

Pharmacology of Alcohol
por: Grossbard, Michael
Publicado: (1983)

Cannot write session to /tmp/vufind_sessions/sess_rvqrqep9tk2uuajjrfh7r1mgp4